Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR-Cas systems
Neurochemistry International · 2026-06 · 196 · 106149
DOI: 10.1016/j.neuint.2026.106149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2026-06. Verfasst von Ravi Pratap Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India. Electronic address: Phdph10007.19@bitmesra…. Hauptthemen laut MEDLINE: Parkinson Disease, CRISPR-Cas Systems, Gene Editing, Genetic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 165 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India. Electronic address: Phdph10007.19@bitmesra.ac.in.
- Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.
- Department of Biotherapeutics Research (DBR) | MAHE, Manipal University, Udupi, Mangalore, India.
Zitieren
APA
Singh, R. P., Maity, P., & Jaiswal, C. (2026). Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR-Cas systems. Neurochemistry International, 196, 106149. https://doi.org/10.1016/j.neuint.2026.106149
Vancouver
Singh RP, Maity P, Jaiswal C. Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR-Cas systems. Neurochemistry International. 2026;196:106149. doi:10.1016/j.neuint.2026.106149
BibTeX
@article{Singh2026,
author = {Singh, Ravi Pratap and Maity, Prasenjit and Jaiswal, Charu},
title = {Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR-Cas systems},
journal = {Neurochemistry International},
year = {2026},
volume = {196},
pages = {106149},
doi = {10.1016/j.neuint.2026.106149}
}
EUVIMED